Share Capital (Details) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Share Capital [Line Items] | ||||
| Authorized shares | 300,000,000 | 300,000,000 | ||
| Shares issued | 1,310,969 | |||
| Issuance of common stock | $ 1,700,000 | |||
| Percentage of common shares issued and outstanding | 15.00% | |||
| Share-based compensation | $ 9,762 | $ 21,476 | $ 46,857 | $ 408,952 |
| Remaining share based compensation | $ 93,714 | $ 93,714 | ||
| Recognized over year | 1 year 6 months | |||
| Contractual term | 8 years 5 months 12 days | |||
| Common Stock [Member] | ||||
| Share Capital [Line Items] | ||||
| Authorized shares | 200,000,000 | 200,000,000 | ||
| Issuance of common stock | $ 1,700,000 | |||
| Intrinsic value of outstanding options | ||||
| Preferred Stock [Member] | ||||
| Share Capital [Line Items] | ||||
| Authorized shares | 100,000,000 | 100,000,000 | ||
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares authorized for issuance under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for option award outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of common shares issued and outstanding. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|